Synopsis

Source of validity: Scientific
Rating (out of 5): 1

Lion's mane mushroom (Hericium erinaceus) has gained attention for its potential neuroprotective and neuroregenerative properties, particularly due to compounds like hericenones and erinacines, which may stimulate nerve growth factor (NGF) synthesis. Multiple sclerosis (MS) is characterized by demyelination and neurodegeneration, so substances promoting nerve repair are of interest. Preclinical studies, particularly in animal models and in vitro experiments, suggest that lion's mane extracts may support neuronal health and enhance remyelination, at least in basic experimental settings. Additionally, limited evidence points to anti-inflammatory and antioxidative effects, which could theoretically be beneficial in MS.

However, current scientific evidence supporting the use of lion’s mane specifically for MS in humans is extremely limited. There are no robust clinical trials evaluating its efficacy in MS patients. Most available data comes from preclinical studies and a few small pilot studies on cognitive health in other conditions. Thus, while there is a plausible biological rationale and some early preclinical signals, direct scientific validation in the context of MS is lacking. The evidence, therefore, is rated as 1 out of 5—suggestive but not yet substantiated by clinical research.

More about lion's mane
More about Multiple Sclerosis

Other ingredients used for Multiple Sclerosis

Other health conditions supported by lion's mane

Products containing lion's mane